Hyperglycemia and hyperlipidemia effective of chickpea has been proven by great quantities of study at home and abroad in recent year, and chickpea product used as a food supplement of diabetes, insulin resistances and low blood glucose disease sufferer, however related function product rarely come out.

　  Key Laboratory of Xinjiang Indigenous Medicinal Plants Resource Utilization, the research team of Professor Hajiakebair engaged in the research of chickpea long time, according to the great deal of foundation research and bioactive compositions of hyperglycemia of chickpea, chickpea deeply process product development made great process.

　  The laboratory set out from the strategy and market policy of Institute, was developed an nutritional product of chickpea that possess assistances of decrease blood sugar and blood glucose, which was supported by “Western Action” project of “Study on Function Constitutions of Chickpea”, the animal experiment results proven that this product has a hyperglycemia and hyperlipidemia effective to II type of diabetes, the technique has gained national invention patent certification (patent number：ZL200710180003.8) as well as a gain a authenticated certificate of “New technique, New product” was issued by economic and trade committee of Xinjiang Uyghur Autonomy Region.

　  Which success of the product development and efficient use of endemic plants in Xinjiang resources - chickpeas, it promotes the process of deep-processing industry and improves products’ competitiveness in the market, and achieves superior agricultural resources in Xinjiang industry to the economy transformation.